img

Global Anti-inflammatory Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-inflammatory Therapy Market Insights, Forecast to 2034

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Market Analysis and InsightsGlobal Anti-inflammatory Therapy Market
Global Anti-inflammatory Therapy market is expected to reach to US$ 118290 million in 2024, with a positive growth of %, compared with US$ 110540 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Anti-inflammatory Therapy industry is evaluated to reach US$ 168750 million in 2029. The CAGR will be 6.1% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Anti-inflammatory Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Anti-inflammatory Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Segment by Type
Corticosteroids
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs
Others

Segment by Application


Respiratory Diseases
Arthritis
Gastroenterology
Dermatology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Anti-inflammatory Therapy introduction, etc. Anti-inflammatory Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Anti-inflammatory Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Corticosteroids
1.2.3 Anti-inflammatory Biologics
1.2.4 Non-Steroidal Anti-inflammatory Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Respiratory Diseases
1.3.3 Arthritis
1.3.4 Gastroenterology
1.3.5 Dermatology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapy Market Perspective (2018-2029)
2.2 Global Anti-inflammatory Therapy Growth Trends by Region
2.2.1 Anti-inflammatory Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anti-inflammatory Therapy Historic Market Size by Region (2018-2024)
2.2.3 Anti-inflammatory Therapy Forecasted Market Size by Region (2024-2029)
2.3 Anti-inflammatory Therapy Market Dynamics
2.3.1 Anti-inflammatory Therapy Industry Trends
2.3.2 Anti-inflammatory Therapy Market Drivers
2.3.3 Anti-inflammatory Therapy Market Challenges
2.3.4 Anti-inflammatory Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Anti-inflammatory Therapy by Players
3.1.1 Global Anti-inflammatory Therapy Revenue by Players (2018-2024)
3.1.2 Global Anti-inflammatory Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Anti-inflammatory Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Anti-inflammatory Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Anti-inflammatory Therapy Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapy Revenue in 2022
3.5 Global Key Players of Anti-inflammatory Therapy Head office and Area Served
3.6 Global Key Players of Anti-inflammatory Therapy, Product and Application
3.7 Global Key Players of Anti-inflammatory Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapy Breakdown Data by Type
4.1 Global Anti-inflammatory Therapy Historic Market Size by Type (2018-2024)
4.2 Global Anti-inflammatory Therapy Forecasted Market Size by Type (2024-2029)
5 Anti-inflammatory Therapy Breakdown Data by Application
5.1 Global Anti-inflammatory Therapy Historic Market Size by Application (2018-2024)
5.2 Global Anti-inflammatory Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anti-inflammatory Therapy Market Size (2018-2029)
6.2 North America Anti-inflammatory Therapy Market Size by Type
6.2.1 North America Anti-inflammatory Therapy Market Size by Type (2018-2024)
6.2.2 North America Anti-inflammatory Therapy Market Size by Type (2024-2029)
6.2.3 North America Anti-inflammatory Therapy Market Share by Type (2018-2029)
6.3 North America Anti-inflammatory Therapy Market Size by Application
6.3.1 North America Anti-inflammatory Therapy Market Size by Application (2018-2024)
6.3.2 North America Anti-inflammatory Therapy Market Size by Application (2024-2029)
6.3.3 North America Anti-inflammatory Therapy Market Share by Application (2018-2029)
6.4 North America Anti-inflammatory Therapy Market Size by Country
6.4.1 North America Anti-inflammatory Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Anti-inflammatory Therapy Market Size by Country (2018-2024)
6.4.3 North America Anti-inflammatory Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapy Market Size (2018-2029)
7.2 Europe Anti-inflammatory Therapy Market Size by Type
7.2.1 Europe Anti-inflammatory Therapy Market Size by Type (2018-2024)
7.2.2 Europe Anti-inflammatory Therapy Market Size by Type (2024-2029)
7.2.3 Europe Anti-inflammatory Therapy Market Share by Type (2018-2029)
7.3 Europe Anti-inflammatory Therapy Market Size by Application
7.3.1 Europe Anti-inflammatory Therapy Market Size by Application (2018-2024)
7.3.2 Europe Anti-inflammatory Therapy Market Size by Application (2024-2029)
7.3.3 Europe Anti-inflammatory Therapy Market Share by Application (2018-2029)
7.4 Europe Anti-inflammatory Therapy Market Size by Country
7.4.1 Europe Anti-inflammatory Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Anti-inflammatory Therapy Market Size by Country (2018-2024)
7.4.3 Europe Anti-inflammatory Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Anti-inflammatory Therapy Market Size (2018-2029)
8.2 China Anti-inflammatory Therapy Market Size by Type
8.2.1 China Anti-inflammatory Therapy Market Size by Type (2018-2024)
8.2.2 China Anti-inflammatory Therapy Market Size by Type (2024-2029)
8.2.3 China Anti-inflammatory Therapy Market Share by Type (2018-2029)
8.3 China Anti-inflammatory Therapy Market Size by Application
8.3.1 China Anti-inflammatory Therapy Market Size by Application (2018-2024)
8.3.2 China Anti-inflammatory Therapy Market Size by Application (2024-2029)
8.3.3 China Anti-inflammatory Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Anti-inflammatory Therapy Market Size (2018-2029)
9.2 Asia Anti-inflammatory Therapy Market Size by Type
9.2.1 Asia Anti-inflammatory Therapy Market Size by Type (2018-2024)
9.2.2 Asia Anti-inflammatory Therapy Market Size by Type (2024-2029)
9.2.3 Asia Anti-inflammatory Therapy Market Share by Type (2018-2029)
9.3 Asia Anti-inflammatory Therapy Market Size by Application
9.3.1 Asia Anti-inflammatory Therapy Market Size by Application (2018-2024)
9.3.2 Asia Anti-inflammatory Therapy Market Size by Application (2024-2029)
9.3.3 Asia Anti-inflammatory Therapy Market Share by Application (2018-2029)
9.4 Asia Anti-inflammatory Therapy Market Size by Region
9.4.1 Asia Anti-inflammatory Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Anti-inflammatory Therapy Market Size by Region (2018-2024)
9.4.3 Asia Anti-inflammatory Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapy Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.1.5 AbbVie Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapy Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapy Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.3.5 Amgen Inc Recent Developments
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Details
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapy Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.4.5 AstraZeneca PLC Recent Developments
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Details
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapy Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.5.5 Pfizer, Inc Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapy Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.6.5 Novartis Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapy Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.7.5 Roche Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapy Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.8.5 Merck Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapy Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.9.5 Sanofi Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapy Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.10.5 GlaxoSmithKline Recent Developments
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Details
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapy Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.12.5 TEVA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti-inflammatory Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Anti-inflammatory Biologics
Table 4. Key Players of Non-Steroidal Anti-inflammatory Drugs
Table 5. Key Players of Others
Table 6. Global Anti-inflammatory Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Anti-inflammatory Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Anti-inflammatory Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Anti-inflammatory Therapy Market Share by Region (2018-2024)
Table 10. Global Anti-inflammatory Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Anti-inflammatory Therapy Market Share by Region (2024-2029)
Table 12. Anti-inflammatory Therapy Market Trends
Table 13. Anti-inflammatory Therapy Market Drivers
Table 14. Anti-inflammatory Therapy Market Challenges
Table 15. Anti-inflammatory Therapy Market Restraints
Table 16. Global Anti-inflammatory Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Anti-inflammatory Therapy Revenue Share by Players (2018-2024)
Table 18. Global Top Anti-inflammatory Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2022)
Table 19. Global Anti-inflammatory Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Anti-inflammatory Therapy, Headquarters and Area Served
Table 22. Global Key Players of Anti-inflammatory Therapy, Product and Application
Table 23. Global Key Players of Anti-inflammatory Therapy, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-inflammatory Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Anti-inflammatory Therapy Revenue Market Share by Type (2018-2024)
Table 27. Global Anti-inflammatory Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Anti-inflammatory Therapy Revenue Market Share by Type (2024-2029)
Table 29. Global Anti-inflammatory Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Anti-inflammatory Therapy Revenue Share by Application (2018-2024)
Table 31. Global Anti-inflammatory Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Anti-inflammatory Therapy Revenue Share by Application (2024-2029)
Table 33. North America Anti-inflammatory Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Anti-inflammatory Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Anti-inflammatory Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Anti-inflammatory Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Anti-inflammatory Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Anti-inflammatory Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Anti-inflammatory Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Anti-inflammatory Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Anti-inflammatory Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Anti-inflammatory Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Anti-inflammatory Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Anti-inflammatory Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Anti-inflammatory Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Anti-inflammatory Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Anti-inflammatory Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Anti-inflammatory Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Anti-inflammatory Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Anti-inflammatory Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Anti-inflammatory Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Anti-inflammatory Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Anti-inflammatory Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Anti-inflammatory Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Anti-inflammatory Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Anti-inflammatory Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Anti-inflammatory Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Anti-inflammatory Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 65. AbbVie Company Details
Table 66. AbbVie Business Overview
Table 67. AbbVie Anti-inflammatory Therapy Product
Table 68. AbbVie Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 69. AbbVie Recent Developments
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Anti-inflammatory Therapy Product
Table 73. Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 74. Johnson & Johnson Recent Developments
Table 75. Amgen Inc Company Details
Table 76. Amgen Inc Business Overview
Table 77. Amgen Inc Anti-inflammatory Therapy Product
Table 78. Amgen Inc Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 79. Amgen Inc Recent Developments
Table 80. AstraZeneca PLC Company Details
Table 81. AstraZeneca PLC Business Overview
Table 82. AstraZeneca PLC Anti-inflammatory Therapy Product
Table 83. AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 84. AstraZeneca PLC Recent Developments
Table 85. Pfizer, Inc Company Details
Table 86. Pfizer, Inc Business Overview
Table 87. Pfizer, Inc Anti-inflammatory Therapy Product
Table 88. Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 89. Pfizer, Inc Recent Developments
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Anti-inflammatory Therapy Product
Table 93. Novartis Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 94. Novartis Recent Developments
Table 95. Roche Company Details
Table 96. Roche Business Overview
Table 97. Roche Anti-inflammatory Therapy Product
Table 98. Roche Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 99. Roche Recent Developments
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Anti-inflammatory Therapy Product
Table 103. Merck Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 104. Merck Recent Developments
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Anti-inflammatory Therapy Product
Table 108. Sanofi Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 109. Sanofi Recent Developments
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Business Overview
Table 112. GlaxoSmithKline Anti-inflammatory Therapy Product
Table 113. GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 114. GlaxoSmithKline Recent Developments
Table 115. Sun Pharmaceutical Industries Ltd Company Details
Table 116. Sun Pharmaceutical Industries Ltd Business Overview
Table 117. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Product
Table 118. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 119. Sun Pharmaceutical Industries Ltd Recent Developments
Table 120. TEVA Company Details
Table 121. TEVA Business Overview
Table 122. TEVA Anti-inflammatory Therapy Product
Table 123. TEVA Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 124. TEVA Recent Developments
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-inflammatory Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Anti-inflammatory Therapy Market Share by Type: 2022 VS 2029
Figure 3. Corticosteroids Features
Figure 4. Anti-inflammatory Biologics Features
Figure 5. Non-Steroidal Anti-inflammatory Drugs Features
Figure 6. Others Features
Figure 7. Global Anti-inflammatory Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Anti-inflammatory Therapy Market Share by Application: 2022 VS 2029
Figure 9. Respiratory Diseases Case Studies
Figure 10. Arthritis Case Studies
Figure 11. Gastroenterology Case Studies
Figure 12. Dermatology Case Studies
Figure 13. Others Case Studies
Figure 14. Anti-inflammatory Therapy Report Years Considered
Figure 15. Global Anti-inflammatory Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Anti-inflammatory Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Anti-inflammatory Therapy Market Share by Region: 2022 VS 2029
Figure 18. Global Anti-inflammatory Therapy Market Share by Players in 2022
Figure 19. Global Top Anti-inflammatory Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapy Revenue in 2022
Figure 21. North America Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Anti-inflammatory Therapy Market Share by Type (2018-2029)
Figure 23. North America Anti-inflammatory Therapy Market Share by Application (2018-2029)
Figure 24. North America Anti-inflammatory Therapy Market Share by Country (2018-2029)
Figure 25. United States Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Anti-inflammatory Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Anti-inflammatory Therapy Market Share by Type (2018-2029)
Figure 29. Europe Anti-inflammatory Therapy Market Share by Application (2018-2029)
Figure 30. Europe Anti-inflammatory Therapy Market Share by Country (2018-2029)
Figure 31. Germany Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Anti-inflammatory Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Anti-inflammatory Therapy Market Share by Type (2018-2029)
Figure 39. China Anti-inflammatory Therapy Market Share by Application (2018-2029)
Figure 40. Asia Anti-inflammatory Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Anti-inflammatory Therapy Market Share by Type (2018-2029)
Figure 42. Asia Anti-inflammatory Therapy Market Share by Application (2018-2029)
Figure 43. Asia Anti-inflammatory Therapy Market Share by Region (2018-2029)
Figure 44. Japan Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Anti-inflammatory Therapy Market Share by Country (2018-2029)
Figure 54. Brazil Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. AbbVie Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 61. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 62. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 63. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 64. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 65. Novartis Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 66. Roche Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 67. Merck Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 68. Sanofi Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 70. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 71. TEVA Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries